Individual InvestorsEmployee ShareholdersInstitutional InvestorsPrivate Companies Accredited Investors Seed & Angel InvestorsAsset Managers & Hedge Funds Family Offices Venture Capital Firms Wealth Managers & RIAsWho We Serve TradingDataLiquidity ProgramsRetirement Individual InvestingForge MarketplaceFind new private company investment opportunitiesBrowse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companies Forge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insightsReports and highlightsNews and trendsPrivate market educationTips and tutorials Forge Investment Outlook Private Market Updates IPO calendar Private Magnificent 7Emerging trends Private company news Upcoming IPOsAll guides Private market basics Private shares transactions Valuations, pricing and market trends Selling in the private market FAQs GlossaryCompany page and trades Proof of ownership Bid and ask submissions Forge fund offeringsInsights About Us Leadership Investor Relations People & Culture Careers About

ArteraAI IPO

$405.79MM

Series Seed-3 Valuation, Feb 2024

Artificial Intelligence

Buy And Sell ArteraAI StockLearn More About ArteraAI StockAdd To Watchlist

ArteraAI IPO date and status

2021

Founded

IPO Mentioned

Confidential Filing

S-1 Filed

IPO

Company details

Artera was founded in 2021 by Andre Esteva. The company has not publicly endorsed plans to participate in an IPO.

Artera is the developer of AI-powered predictive and prognostic cancer tests. The company's flagship product, the ArteraAI Prostate test, aims to predict the benefits of therapy for patients with localized prostate cancer. As of the public launch in March 2023, Artera had raised $90 million in venture capital funding from investors including Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, and Marc Benioff. Artera did not disclose valuation figures at the time of launch.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

artera.ai

Sector

Healthcare

Subsector

Biotech & Pharma

Founded

2021

Headquarters

Los Altos, CA, United States

Founders

Andre Esteva, Ph.D., Felix Feng, M.D.

Forge Price ¹

Price not yet available

Market Activity ²

Limited

Last Matched Price

Get Full Access

Post-Money Valuation ³

$405.79MM

Total Funding

$95.75MM

Last Funding Round

Series Seed-3

Learn more about ArteraAI

To invest in ArteraAI pre-IPO

Can you invest in ArteraAI pre-IPO?

ArteraAI is privately held and not traded on public markets, so pre-IPO investments are available only to accredited investors.

If you’re already accredited and have completed Forge’s verification, you can visit our marketplace to review and invest in private companies ahead of an IPO.

If you haven’t yet completed your accredited investor verification with Forge, you can start that process now to unlock access to new private-company offerings.

For more on who qualifies—and how to get verified—see our blog “Accredited investors, qualified clients and qualified purchasers: Who can invest?”

Can you sell shares of ArteraAI before it goes public?

Yes, subject to any contractual or corporate transfer restrictions, it is possible to list your shares to sell while ArteraAI is still private. If you’re considering selling, you can register today for free to get started. Once registered, you can evaluate pricing insights and market activity to inform your decision, then post your shares for sale and set the terms, like quantity and price—all directly through our platform.

If you’d like additional guidance at any point, Forge private market specialists are available to help. For a step-by-step overview, check out our seller’s guide.

What is the pre-IPO value of my ArteraAI shares?

To explore the value of your ArteraAI shares, create a free account to access Forge’s marketplace. Once inside, you’ll find several pricing insights to help guide your decision—these include historical transaction data, a live order book showing current buy and sell interest, and Forge Price™, a derived, indicative price based on recent transactions, investor activity, and other relevant market data.

These insights can help you determine a price you’re comfortable with if you choose to sell your shares. If you’d like additional guidance along the way, Forge private market specialists are available to help. You can also review our seller’s guide for a step-by-step overview.

Is ArteraAI a publicly traded company?

ArteraAI is a private company and not publicly traded.

If you’re interested in buying or selling shares in private companies, you can register with Forge today for free to explore available opportunities. Once registered, you’ll gain access to our marketplace, where you can view active buy and sell interest, evaluate pricing signals and take action directly through the platform.

To learn more about ArteraAI potential IPO

Will ArteraAI go IPO?

ArteraAI has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2025.

What is ArteraAI’s IPO price?

The ArteraAI IPO price does not exist at this time, as ArteraAI is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to ArteraAI, register for Forge today.

When was ArteraAI founded?

ArteraAI was founded in 2021.

What is ArteraAI funding to date?

ArteraAI has raised $95.75MM to date.

ArteraAI major investors

Breyer Capital

Coatue Management

Factoryhq

Johnson & Johnson Innovation

Koch Disruptive Technologies

Time Ventures

Walden Catalyst

Show All InvestorsShow Fewer Investors

ArteraAI pre-IPO valuation and funding rounds

Funding history chart

Funding round and deals details

	Funding Date	Round	Amount Raised	Price per Share	Post-Money Valuation ³	Key Investors
	02/01/2024	Series Seed-3	$81.25MM	$7.95	$405.79MM	Amarjit Gill, Andrew Tan, Andy Jacques, Breyer Capital, Chris Re, Clarence So, Coatue, Dennis Wong, Edbi, Elliott Tan, Jeff Dean, Jim Breyer, Johnson & Johnson Innovation, Koch Disruptive Technologies, Lip-Bu Tan, Marc Benioff, Michael Driscoll, Navin Chaddha, Prosperity7 Ventures, Rajiv Khemani, Steve Blank, The Factory, Time Ventures, Trium Ventures, Walden Catalyst, Wilson Sonsini Goodrich & Rosati
Price per Share $ xx.xx Shares Outstanding 10,217,833 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Amarjit Gill, Andrew Tan, Andy Jacques, Breyer Capital, Chris Re, Clarence So, Coatue, Dennis Wong, Edbi, Elliott Tan, Jeff Dean, Jim Breyer, Johnson & Johnson Innovation, Koch Disruptive Technologies, Lip-Bu Tan, Marc Benioff, Michael Driscoll, Navin Chaddha, Prosperity7 Ventures, Rajiv Khemani, Steve Blank, The Factory, Time Ventures, Trium Ventures, Walden Catalyst, Wilson Sonsini Goodrich & Rosati
	02/01/2024	Series Seed-2	$14.3MM	$2.37	$405.79MM	Amarjit Gill, Andrew Tan, Andy Jacques, Breyer Capital, Chris Re, Clarence So, Coatue, Dennis Wong, Edbi, Elliott Tan, Jeff Dean, Jim Breyer, Johnson & Johnson Innovation, Koch Disruptive Technologies, Lip-Bu Tan, Marc Benioff, Michael Driscoll, Navin Chaddha, Prosperity7 Ventures, Rajiv Khemani, Steve Blank, The Factory, Time Ventures, Trium Ventures, Walden Catalyst, Wilson Sonsini Goodrich & Rosati
Price per Share $ xx.xx Shares Outstanding 6,030,037 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Amarjit Gill, Andrew Tan, Andy Jacques, Breyer Capital, Chris Re, Clarence So, Coatue, Dennis Wong, Edbi, Elliott Tan, Jeff Dean, Jim Breyer, Johnson & Johnson Innovation, Koch Disruptive Technologies, Lip-Bu Tan, Marc Benioff, Michael Driscoll, Navin Chaddha, Prosperity7 Ventures, Rajiv Khemani, Steve Blank, The Factory, Time Ventures, Trium Ventures, Walden Catalyst, Wilson Sonsini Goodrich & Rosati
	02/01/2024	Series Seed-1	$199,999.98	$0.03	$405.79MM	Amarjit Gill, Andrew Tan, Andy Jacques, Breyer Capital, Chris Re, Clarence So, Coatue, Dennis Wong, Edbi, Elliott Tan, Jeff Dean, Jim Breyer, Johnson & Johnson Innovation, Koch Disruptive Technologies, Lip-Bu Tan, Marc Benioff, Michael Driscoll, Navin Chaddha, Prosperity7 Ventures, Rajiv Khemani, Steve Blank, The Factory, Time Ventures, Trium Ventures, Walden Catalyst, Wilson Sonsini Goodrich & Rosati
Price per Share $ xx.xx Shares Outstanding 7,168,458 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Amarjit Gill, Andrew Tan, Andy Jacques, Breyer Capital, Chris Re, Clarence So, Coatue, Dennis Wong, Edbi, Elliott Tan, Jeff Dean, Jim Breyer, Johnson & Johnson Innovation, Koch Disruptive Technologies, Lip-Bu Tan, Marc Benioff, Michael Driscoll, Navin Chaddha, Prosperity7 Ventures, Rajiv Khemani, Steve Blank, The Factory, Time Ventures, Trium Ventures, Walden Catalyst, Wilson Sonsini Goodrich & Rosati

ArteraAI IPO news and media highlights

FierceHealthcare 06/21/2023

Tech company Artera launches solution to help health systems manage all those texts, emails to patients

Health systems have made big investments in the past few years to build out "digital front doors" for patients. But in many cases, all these "doors" lead down different hallways, resulting in a fragmented, disjointed experience for patients. All these communication tools also cause headaches for healthcare staff to manage.

Crunchbase News 03/21/2023

Cancer-Testing Startup Artera Raises $90M

Artera, which uses artificial intelligence for cancer testing and personalized care, raised a $90 million round to support the distribution of its flagship test in prostate cancer.

Axios 03/21/2023

Artera snags $90M for prostate cancer test

Artera, a medical company developing AI tests to personalize therapy for cancer patients, raised $90 million, the company tells Axios exclusively.

Healio 02/16/2023

Multimodal AI biomarker may help personalize decision-making in high-risk prostate cancer

An artificial intelligence-derived biomarker enabled improved risk stratification for men with high-risk prostate cancer, according to study results presented at ASCO Genitourinary Cancers Symposium.

Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare

Subsector: Biotech & Pharma

Trade Metrics				Last Funding Round
Company		Forge Price	Last Matched	Round	Post-Money Valuation ³	Price Per Share	Amount Raised
	VeraDermics	Not available	$ xx.xx	Series C	$306.13MM	$1.27	$151MM
	Eikon Therapeutics	Not available	$ xx.xx	Series D	$1.57B	$5.84	$326.93MM
	Spyglass Pharma	Not available	$ xx.xx	Series D	$350.04MM	$2.33	$75MM
	Affinia Therapeutics	Not available	$ xx.xx	Series C	$156.61MM	$1.62	$40MM
	Origin	Not available	$ xx.xx	Not available	--	--	--

See Tech IPO Calendar

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company	Forge Price	Market Activity	Last Matched
SpaceX	$447.23 -$2.12 (0.47%)	High	$xxx.xx
Anthropic	$259.14 -$13.84 (5.07%)	High	$xxx.xx
OpenAI	$723.12 +$0.12 (0.02%)	High	$xxx.xx
Anduril	$105.00 -$0.53 (0.50%)	High	$xxx.xx
Databricks	$197.72 +$0.06 (0.03%)	High	$xxx.xx

See All Actively Traded Companies

Artificial Intelligence (AI)

Company	Forge Price	Market Activity	Last Matched
Anthropic	$259.14 -$13.84 (5.07%)	High	$xxx.xx
OpenAI	$723.12 +$0.12 (0.02%)	High	$xxx.xx
Anduril	$105.00 -$0.53 (0.50%)	High	$xxx.xx
Databricks	$197.72 +$0.06 (0.03%)	High	$xxx.xx
Waymo	Not available	Limited	$xxx.xx

See All AI Companies

Forge, your trusted partner for pre-IPO insights and Artera data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Feb 3, 2026

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.